The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

BAYRY beats on Q2 earnings and raises 2025 sales outlook (on a currency-adjusted basis) as pharma growth offsets currency and ...

The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July ...

We affirm our objective to significantly contain the litigation risk by the end of 2026,” CEO Bill Anderson noted said. As part of its ...

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of ...

Bayer has cut more than one in 10 jobs since the launch of a sweeping restructuring programme aimed at streamlining decision-making and reducing layers of management.

A French court ruled on Thursday that a complaint brought by a family against Bayer claiming their son's disabilities were ...

Glyphosate Squeeze Bayer didn’t quantify just how much of an impact it will have on overall production, but says it’s continuing to work diligently with customers to address their needs.

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

Bayer has applied for approval in the EU of its new herbicide, icafolin, following applications in Brazil, the US, and Canada ...

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...

In a judgment handed down Thursday, the court ruled that the severe birth defects of Théo Grataloup, now 18, could not be attributed to in utero exposure to glyphosate.